The fourth red flag concerns a new obligation the recommendations impose on companies and sponsors submitting to the HTA process and the peculiar absence of any focus on a critical issue considered an Albanese Government priority. …
The HTA Review report - 'Red Flag' number four of five
September 18, 2024 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
Clear political leadership delivers green shoots in New Zealand
September 18, 2024 - - Latest News -
AusBiotech pays tribute to a leading figure in the creation of Australia's biotech sector
September 18, 2024 - - Latest News -
Pharmac continues to invest its post-Budget funding boost
September 18, 2024 - - Latest News -
The HTA Review report - 'Red Flag' number four of five
September 18, 2024 - - Latest News -
Wesfarmers Health announces plan to build new fulfilment centre in Cairns
September 17, 2024 - - Latest News -
Medicines Australia launches next phase of campaign in PM's electorate
September 17, 2024 - - Latest News -
The HTA Review report - 'Red Flag' number three of five
September 17, 2024 - - Latest News